The downregulation of ALOX15, both in our HYPO vs. NORMO comparison, and in the in-hospital mortality comparison for the Baghela et al. study, may indicate important downregulation of pro-resolving anti-inflammatory lipids and metabolites of eicosanoids, which may potentiate the dysregulated inflammation of sepsis. The gene discussed is ALOX15; the disease is Sepsis.